title: Human lung deposition of particles suspended in air or in helium/oxygen mixture.
abstract: Deposition in mouth and throat and the fraction of alveolarly deposited particles in the lung of 3.6- to 3.8-microns Teflon particles labeled with 99mTc were estimated in nine healthy subjects. The particles were inhaled in air or helium/oxygen mixture with a flow of 0.5 l/s by subjects with or without induced bronchoconstriction. The bronchoconstriction (two- to threefold increase in airway resistance) was induced by an aerosol of methacholine bromide. As the Reynolds number is three times lower for the helium/oxygen mixture than for air, and the sedimentation rate of the particles is about the same in both, a different regional deposition between particles suspended in air and helium/oxygen mixture should be due to turbulence. Deposition in mouth and throat did not differ significantly between air and the helium/oxygen mixture. The alveolarly deposited fraction tended to be larger for unconstricted airways and was significantly larger for constricted airways for inhalations in the helium/oxygen mixture compared to air. In real life, air pollutants and therapeutic aerosols may be inhaled with larger flow rates and broncho-constriction may be more pronounced in patients, so that deposition of particles due to turbulence can be important.
authors.affiliation: Department of Environmental Hygiene, Karolinska Institute, Stockholm, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Svartengren
authors.forename: M
authors.initials: M
authors.lastname: Anderson
authors.forename: K
authors.initials: K
authors.lastname: Philipson
authors.forename: P
authors.initials: P
authors.lastname: Camner
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D001980:Bronchi / Q000378:metabolism*; D005260:Female; D006371:Helium / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000494:pharmacology; D008863:Microspheres; D009055:Mouth / Q000378:metabolism*; D010100:Oxygen / Q000493:pharmacokinetics*; D010614:Pharynx / Q000378:metabolism*; D011138:Polytetrafluoroethylene
chemical_list: D008688:Methacholine Compounds; D016210:Methacholine Chloride; D006371:Helium; D011138:Polytetrafluoroethylene; D010100:Oxygen